Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2018 $ 479,000 $ 543,754,000 $ (410,188,000) $ 134,045,000
Beginning balance, shares at Dec. 31, 2018 47,944,486        
Stock option-based compensation expense 5,607,000 5,607,000
Restricted stock-based compensation expense 348,000 348,000
Issuance of common stock in connection with restricted share awards $ 4,000 (4,000)
Issuance of common stock in connection with restricted share awards, shares 376,625        
Common stock issued for cash under open market sale agreement $ 32,000 16,930,000 16,962,000
Common stock issued for cash under open market sale agreement, shares 3,086,950        
Common stock issued for cash exercise of options $ 1,000 412,000 413,000
Common stock issued for cash exercise of options, shares 96,334        
Shares returned in connection with arbitration ruling on licensing agreement $ (5,000) (1,467,000) (1,472,000)
Shares returned in connection with arbitration ruling on licensing agreement, shares (450,000)        
Net loss (59,851,000) (59,851,000)
Other comprehensive income        
Ending balance, value at Sep. 30, 2019 $ 511,000 565,580,000 (470,039,000) 96,052,000
Ending balance, shares at Sep. 30, 2019 51,054,395        
Beginning balance, value at Jun. 30, 2019 $ 492,000 559,335,000 (452,667,000) 107,160,000
Beginning balance, shares at Jun. 30, 2019 49,249,497        
Stock option-based compensation expense 1,826,000 1,826,000
Restricted stock-based compensation expense 98,000 98,000
Issuance of common stock in connection with restricted share awards $ 4,000 (4,000)
Issuance of common stock in connection with restricted share awards, shares 376,625        
Common stock issued for cash under open market sale agreement $ 15,000 4,325,000 4,340,000
Common stock issued for cash under open market sale agreement, shares 1,428,273        
Net loss (17,372,000) (17,372,000)
Other comprehensive income        
Ending balance, value at Sep. 30, 2019 $ 511,000 565,580,000 (470,039,000) 96,052,000
Ending balance, shares at Sep. 30, 2019 51,054,395        
Beginning balance, value at Dec. 31, 2019 $ 836,000 664,064,000 (486,470,000) 178,430,000
Beginning balance, shares at Dec. 31, 2019 83,622,135        
Stock option-based compensation expense 4,083,000 4,083,000
Restricted stock-based compensation expense 812,000 812,000
Common stock issued for cash exercise of options $ 1,000 174,000 175,000
Common stock issued for cash exercise of options, shares 75,793        
Issuance of common stock in connection with restricted share awards, net of cancellations $ 8,000 (8,000)
Issuance of common stock in connection with restricted share awards, net of cancellations, shares 818,233        
Net loss (68,406,000) (68,406,000)
Other comprehensive income 17,000 17,000
Ending balance, value at Sep. 30, 2020 $ 845,000 669,125,000 (554,876,000) 17,000 115,111,000
Ending balance, shares at Sep. 30, 2020 84,516,161        
Beginning balance, value at Jun. 30, 2020 $ 848,000 667,712,000 (547,639,000) 133,000 121,054,000
Beginning balance, shares at Jun. 30, 2020 84,781,241        
Stock option-based compensation expense 1,249,000 1,249,000
Restricted stock-based compensation expense 161,000 161,000
Cancellation of restricted share awards $ (3,000) 3,000
Cancellation of restricted share awards, shares (265,080)        
Issuance of common stock in connection with restricted share awards, shares        
Net loss (7,237,000) (7,237,000)
Other comprehensive income (116,000) (116,000)
Ending balance, value at Sep. 30, 2020 $ 845,000 $ 669,125,000 $ (554,876,000) $ 17,000 $ 115,111,000
Ending balance, shares at Sep. 30, 2020 84,516,161